Expertise in
18
conditions

Dr. Mahesh Kudrimoti

Radiation Oncology
Radiation Oncology-Dearborn Cancer Center-St. Elizabeth Healthcare
17525 Greendale Plaza Dr, 
Greendale, IN 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
18
conditions
Radiation Oncology-Dearborn Cancer Center-St. Elizabeth Healthcare
17525 Greendale Plaza Dr, 
Greendale, IN 

Overview

Mahesh Kudrimoti is a Radiation Oncologist practicing medicine in Greendale, Indiana.

Dr. Kudrimoti is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Fibrolamellar Carcinoma, Teratocarcinosarcoma, and Pancreaticoduodenectomy.

He is actively involved in clinical research, co-authoring 41 peer reviewed articles and participating in 6 clinical trials.

Specialties

Radiation Oncology

Licenses

Radiology in KY

Hospital Affiliations

St Elizabeth Edgewood
St Elizabeth Dearborn Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
MDwise
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

Radiation Oncology-Dearborn Cancer Center-St. Elizabeth Healthcare
17525 Greendale Plaza Dr, Greendale, IN 47025

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer
Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer
Enrollment Status: Recruiting
Publish Date: April 03, 2026
Intervention Type: Procedure, Drug, Other
Study Phase: Phase 2/Phase 3
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Other, Procedure, Drug, Biological, Radiation
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 2/Phase 3
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
Enrollment Status: Completed
Publish Date: February 23, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Capecitabine, Chemotherapy, Erlotinib hydrochloride, Fluorouracil, Gemcitabine hydrochloride
Study Phase: Phase 3
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 06, 2026
Intervention Type: Biological, Radiation
Study Drug: Cetuximab
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of GC4419 on Severe Oral Mucositis in Patients Receiving Cisplatin + Intensity-modulated Radiation Therapy (IMRT) for Locally Advanced Non-Metastatic Squamous Cell Carcinoma (SCC) of the Oral Cavity/Oropharynx
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of GC4419 on Severe Oral Mucositis in Patients Receiving Cisplatin + Intensity-modulated Radiation Therapy (IMRT) for Locally Advanced Non-Metastatic Squamous Cell Carcinoma (SCC) of the Oral Cavity/Oropharynx
Enrollment Status: Completed
Publish Date: September 20, 2021
Intervention Type: Radiation, Drug
Study Phase: Phase 2
Correlative Study of Nicotine Levels With Response Rates to Therapy Using Radiation Alone or in Combination With Chemotherapy in Head and Neck Cancer
Correlative Study of Nicotine Levels With Response Rates to Therapy Using Radiation Alone or in Combination With Chemotherapy in Head and Neck Cancer
Enrollment Status: Completed
Publish Date: July 14, 2021
View 5 Less Clinical Trials

41 Total Publications

A Two-Stage Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ec-18 in Altering the Severity and Course of Oral Mucositis Secondary to Chemoradiation Therapy for Squamous Cell Cancers of the Head and Neck.
A Two-Stage Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ec-18 in Altering the Severity and Course of Oral Mucositis Secondary to Chemoradiation Therapy for Squamous Cell Cancers of the Head and Neck.
Journal: Cancers
Published: March 30, 2025
Similar Doctors
Expertise in
17
conditions
Dr. Jordan Kharofa
Radiation Oncology
Expertise in
17
conditions
Dr. Jordan Kharofa
Radiation Oncology

Barrett Building-Breast Imaging

3151 Bellevue Ave, 
Cincinnati, OH 
 (17.6 miles away)
513-584-3494
Languages Spoken:
English
See accepted insurances

Jordan Kharofa is a Radiation Oncologist practicing medicine in Cincinnati, Ohio. Dr. Kharofa is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Anal Cancer, Pancreatic Cancer, Vaginal Cancer, Endometrial Cancer, and Pancreaticoduodenectomy.

Expertise in
6
conditions
Dr. Vinita Takiar
Radiation Oncology
Expertise in
6
conditions
Dr. Vinita Takiar
Radiation Oncology

Barrett Building-Breast Imaging

3151 Bellevue Ave, 
Cincinnati, OH 
 (17.6 miles away)
513-584-3494
Languages Spoken:
English
See accepted insurances

Vinita Takiar is a Radiation Oncologist practicing medicine in Cincinnati, Ohio. Dr. Takiar is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, Laryngeal Cancer, Oral Squamous Cell Carcinoma, and Gastrostomy.

Expertise in
28
conditions
Dr. Pratish Shah
Radiation Oncology
Expertise in
28
conditions
Dr. Pratish Shah
Radiation Oncology

Radiation Oncology-Edgewood Cancer Center-St. Elizabeth Healthcare

1 Medical Village Dr, 
Edgewood, KY 
 (16.9 miles away)
859-301-2238
Languages Spoken:
English
See accepted insurances

Pratish Shah is a Radiation Oncologist practicing medicine in Edgewood, Kentucky. Dr. Shah is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), Posterior Fossa Tumor, and Gamma Knife Radiosurgery.

Frequently Asked Questions about Dr. Mahesh Kudrimoti

How do I make an appointment with Dr. Mahesh Kudrimoti?

You can book an appointment with Dr. Mahesh Kudrimoti by calling their office at 859-301-2238. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mahesh Kudrimoti a top-rated expert for Laryngeal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mahesh Kudrimoti is classified as an Distinguished expert for Laryngeal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mahesh Kudrimoti specialize in?

While Dr. Mahesh Kudrimoti is a Radiation Oncology, they have specific expertise in Laryngeal Cancer, Throat Cancer, and Fibrolamellar Carcinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Mahesh Kudrimoti participate in research or clinical trials?

Yes. Dr. Mahesh Kudrimoti has published 41 articles and abstracts on conditions like Laryngeal Cancer. You can view a list of Dr. Mahesh Kudrimoti's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mahesh Kudrimoti accept my insurance?

Dr. Mahesh Kudrimoti accepts most major insurance plans, including Anthem BCBS and Blue Cross Blue Shield. We recommend calling the office directly at 859-301-2238 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kudrimoti's expertise for a condition
ConditionClose
    View All 13 Advanced Conditions
    View All 61 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile